BridgeMD
Tests treatment safety and results for HIV Infections
Official title HeadStART: Evaluating the Effectiveness of Community ART Delivery for People Newly Diagnosed With HIV
ClinicalTrials.gov ID: NCT06126913
What this study is testing
- What it's testing
- This is a cluster randomized controlled trial at 12 health centers in refugee settlements in Uganda aiming to evaluate effectiveness of expansion of community antiretroviral therapy (ART) delivery to people newly diagnosed with HIV in achieving HIV viral suppression.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Adults
You may be able to join if
- Evidence of a personally signed and dated informed consent document indicating that the subject (or a legal representative) has been informed of all...
- people who are willing and able to comply with scheduled visits, treatment plan, laboratory tests, and other study procedures.
- Adult ≥18 years of age or mature minors or emancipated minor. Mature minors are defined as individuals 14-17 years of age who have drug or alcohol...
- Tested HIV positive in the past 6 months and not already known to be HIV positive.
- Able to communicate in one of the following 5 study languages: Kiswahili, Runyankore, Kinyarwanda, Somali, or English. for data abstraction only:
You likely can't join if
- Pregnant and breastfeeding women.
- Clients deemed by the clinician(s) unfit for community-based care secondary to medical need.
- Concurrently enrolled in another biomedical clinical trial.
See the full eligibility criteria
- Evidence of a personally signed and dated informed consent document indicating that the subject (or a legal representative) has been informed of all pertinent aspects of the study.
- people who are willing and able to comply with scheduled visits, treatment plan, laboratory tests, and other study procedures.
- Adult ≥18 years of age or mature minors or emancipated minor. Mature minors are defined as individuals 14-17 years of age who have drug or alcohol dependency or a sexually transmitted infection. Emancipated minors are...
- Tested HIV positive in the past 6 months and not already known to be HIV positive.
- Able to communicate in one of the following 5 study languages: Kiswahili, Runyankore, Kinyarwanda, Somali, or English. for data abstraction only:
- Adult ≥18 years of age or mature minors or emancipated minor.
- Tested HIV positive in the past 6 months and not already known to be HIV positive.
- Pregnant and breastfeeding women.
- Clients deemed by the clinician(s) unfit for community-based care secondary to medical need.
- Concurrently enrolled in another biomedical clinical trial.
The study team makes the final eligibility decision.
Where it's taking place
- Kampala, Uganda
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, not specified. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Kampala, Uganda. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.